$100M Series C for Cadence Signals AI's Push into Chronic Care Automation
Event summary
- $100M Series C led by Spark Capital, with participation from 7 other investors.
- Partnerships expanded to include Duke Health and Texas Health Resources, bringing total health system affiliations to over 20.
- Treats more than 100,000 active patients, saving Medicare approximately $2.7 million weekly.
- Tripled annual recurring revenue in 2025.
The big picture
Cadence's funding and partnerships underscore the growing industry shift toward AI-driven chronic care management, aiming to address the clinical labor shortage and high costs of unmanaged chronic diseases. The company's ability to demonstrate peer-reviewed outcomes and economic proof positions it as a potential model for bending the healthcare cost curve through technology.
What we're watching
- Scale and Adoption
- Whether Cadence can sustain its rapid growth across new health systems while maintaining clinical outcomes.
- AI Integration
- The pace at which AI agents advance in sophistication and regulatory acceptance within care delivery workflows.
- Value-Based Care
- How effectively Cadence can expand its value-based care models to further reduce healthcare costs without compromising quality.
Related topics
